P1090: LONG TERM FOLLOW-UP OF UNTREATED/RELAPSING MCL PATIENTS WITH THE IBRUTINIB, OBINUTUZUMAB, AND VENETOCLAX COMBINATION.

• Steven Le Gouill,
• Franck Morschhauser,
• David Chiron,
• Kamal Bouabdallah,
• Guillaume Cartron,
• Rene Olivier Casasnovas,
• Caroline Milin,
• Charles Herbaux,
• Emmanuelle Tchernonog,
• Cedric Rossi,
• Simon Rule,
• Thomas Gastinne,
• Mary Callanan,
• Benoit Tessoulin

Affiliations

Steven Le Gouill

1 Curie, Paris, France

Franck Morschhauser

2 Lille University Hospital, Lille, France

David Chiron

3 CRCI²NA, Nantes, France

Kamal Bouabdallah

4 Bordeaux university Hospital, Bordeaux, France

Guillaume Cartron

5 Montpellier University Hospital, Montpellier, France

Rene Olivier Casasnovas

6 Dijon University Hospital, Dijon, France

Caroline Milin

7 Nantes University Hospital, Nantes, France

Charles Herbaux

5 Montpellier University Hospital, Montpellier, France

Emmanuelle Tchernonog

5 Montpellier University Hospital, Montpellier, France

Cedric Rossi

6 Dijon University Hospital, Dijon, France

Simon Rule

8 Astrazeneca Canada, Mississauga, Canada

Thomas Gastinne

9 Nantes University Hospital, Hematology, Nantes, France

Mary Callanan

6 Dijon University Hospital, Dijon, France

Benoit Tessoulin

7 Nantes University Hospital, Nantes, France